fanta.bio Sample: CNhs11723
17508 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1236 / 15151 (8.2%) | 357 / 151510 (0.2%) | −324.0 | −324.0 | 34.62 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1801 / 15151 (11.9%) | 622 / 151510 (0.4%) | −324.0 | −324.0 | 28.95 |
| HIF1A SRX11007095 | HK-2 Kidney | 2238 / 15151 (14.8%) | 822 / 151510 (0.5%) | −324.0 | −324.0 | 27.23 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1641 / 15151 (10.8%) | 708 / 151510 (0.5%) | −324.0 | −324.0 | 23.18 |
| TP53 SRX19538279 | Osteoblasts Bone | 534 / 15151 (3.5%) | 236 / 151510 (0.2%) | −324.0 | −324.0 | 22.63 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2315 / 15151 (15.3%) | 1061 / 151510 (0.7%) | −324.0 | −324.0 | 21.82 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2248 / 15151 (14.8%) | 1052 / 151510 (0.7%) | −324.0 | −324.0 | 21.37 |
| SCML2 SRX644728 | 293 Kidney | 1312 / 15151 (8.7%) | 735 / 151510 (0.5%) | −324.0 | −324.0 | 17.85 |
| FOXP1 SRX736067 | LNCAP Prostate | 1729 / 15151 (11.4%) | 1084 / 151510 (0.7%) | −324.0 | −324.0 | 15.95 |
| MYH11 SRX265221 | ME-1 Blood | 801 / 15151 (5.3%) | 561 / 151510 (0.4%) | −324.0 | −324.0 | 14.28 |
| BRD4 SRX9419935 | BT-474 Breast | 3484 / 15151 (23.0%) | 2539 / 151510 (1.7%) | −324.0 | −324.0 | 13.72 |
| MED1 SRX9419944 | BT-474 Breast | 3381 / 15151 (22.3%) | 2530 / 151510 (1.7%) | −324.0 | −324.0 | 13.36 |
| MED1 SRX9419945 | BT-474 Breast | 3433 / 15151 (22.7%) | 2576 / 151510 (1.7%) | −324.0 | −324.0 | 13.33 |
| BRD4 SRX9419937 | BT-474 Breast | 3435 / 15151 (22.7%) | 2591 / 151510 (1.7%) | −324.0 | −324.0 | 13.26 |
| BRD4 SRX9419936 | BT-474 Breast | 3526 / 15151 (23.3%) | 2685 / 151510 (1.8%) | −324.0 | −324.0 | 13.13 |
| MED1 SRX9419946 | BT-474 Breast | 3514 / 15151 (23.2%) | 2686 / 151510 (1.8%) | −324.0 | −324.0 | 13.08 |
| BRD4 SRX9419938 | BT-474 Breast | 3496 / 15151 (23.1%) | 2706 / 151510 (1.8%) | −324.0 | −324.0 | 12.92 |
| MED1 SRX9419947 | BT-474 Breast | 3402 / 15151 (22.5%) | 2635 / 151510 (1.7%) | −324.0 | −324.0 | 12.91 |
| EZH2 SRX2146136 | LNCAP Prostate | 7560 / 15151 (49.9%) | 7280 / 151510 (4.8%) | −324.0 | −324.0 | 10.38 |
| BRD4 SRX736201 | 90-8TL Neural | 5980 / 15151 (39.5%) | 5936 / 151510 (3.9%) | −324.0 | −324.0 | 10.07 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1757 / 15151 (11.6%) | 2460 / 151510 (1.6%) | −324.0 | −324.0 | 7.14 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1435 / 15151 (9.5%) | 3259 / 151510 (2.2%) | −324.0 | −324.0 | 4.40 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1659 / 15151 (10.9%) | 4444 / 151510 (2.9%) | −324.0 | −324.0 | 3.73 |
| KAT7 SRX101303 | RKO Digestive tract | 1557 / 15151 (10.3%) | 4470 / 151510 (3.0%) | −324.0 | −324.0 | 3.48 |
| AGO2 SRX4708039 | Hep G2 Liver | 1995 / 15151 (13.2%) | 6637 / 151510 (4.4%) | −324.0 | −324.0 | 3.01 |
| TP53 SRX19538274 | U2OS Bone | 440 / 15151 (2.9%) | 156 / 151510 (0.1%) | −319.7 | −316.5 | 28.21 |
| TP53 SRX19538268 | U2OS Bone | 431 / 15151 (2.8%) | 151 / 151510 (0.1%) | −314.1 | −311.0 | 28.54 |
| TP53 SRX19538276 | U2OS Bone | 434 / 15151 (2.9%) | 157 / 151510 (0.1%) | −313.6 | −310.5 | 27.64 |
| BRD1 SRX286203 | RKO Digestive tract | 1316 / 15151 (8.7%) | 3599 / 151510 (2.4%) | −293.5 | −290.4 | 3.66 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 672 / 15151 (4.4%) | 825 / 151510 (0.5%) | −293.0 | −289.9 | 8.15 |
| HIF1A SRX20663235 | HK-2 Kidney | 457 / 15151 (3.0%) | 246 / 151510 (0.2%) | −292.4 | −289.4 | 18.58 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 686 / 15151 (4.5%) | 886 / 151510 (0.6%) | −289.8 | −286.7 | 7.74 |
| TP53 SRX19538267 | U2OS Bone | 390 / 15151 (2.6%) | 128 / 151510 (0.1%) | −288.9 | −285.9 | 30.47 |
| Epitope tags SRX10549776 | K-562 Blood | 1496 / 15151 (9.9%) | 4640 / 151510 (3.1%) | −286.3 | −283.3 | 3.22 |
| TP53 SRX19538275 | U2OS Bone | 399 / 15151 (2.6%) | 150 / 151510 (0.1%) | −285.2 | −282.3 | 26.60 |
| TP53 SRX19538273 | U2OS Bone | 387 / 15151 (2.6%) | 134 / 151510 (0.1%) | −282.8 | −279.8 | 28.88 |
| BRPF3 SRX796086 | RKO Digestive tract | 1558 / 15151 (10.3%) | 5078 / 151510 (3.4%) | −279.1 | −276.1 | 3.07 |
| BRPF3 SRX796084 | RKO Digestive tract | 1610 / 15151 (10.6%) | 5396 / 151510 (3.6%) | −277.5 | −274.5 | 2.98 |
| TP53 SRX19538280 | Osteoblasts Bone | 412 / 15151 (2.7%) | 191 / 151510 (0.1%) | −276.9 | −274.0 | 21.57 |
| BRPF3 SRX796085 | RKO Digestive tract | 1176 / 15151 (7.8%) | 3105 / 151510 (2.0%) | −272.1 | −269.2 | 3.79 |
| TP53 SRX19538281 | Osteoblasts Bone | 441 / 15151 (2.9%) | 265 / 151510 (0.2%) | −271.1 | −268.2 | 16.64 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 411 / 15151 (2.7%) | 203 / 151510 (0.1%) | −270.6 | −267.7 | 20.25 |
| PBX4 SRX2731658 | PC-3 Prostate | 918 / 15151 (6.1%) | 23605 / 151510 (15.6%) | −264.4 | −261.5 | 0.39 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 632 / 15151 (4.2%) | 830 / 151510 (0.5%) | −263.9 | −261.0 | 7.61 |
| MEAF6 DRX234811 | 293 Kidney | 1776 / 15151 (11.7%) | 6586 / 151510 (4.3%) | −263.4 | −260.6 | 2.70 |
| TP53 SRX19538269 | U2OS Bone | 477 / 15151 (3.1%) | 377 / 151510 (0.2%) | −261.9 | −259.0 | 12.65 |
| RUNX1 SRX2513054 | 293 Kidney | 3138 / 15151 (20.7%) | 15952 / 151510 (10.5%) | −261.3 | −258.5 | 1.97 |
| MEAF6 DRX300417 | 293 Kidney | 1638 / 15151 (10.8%) | 5789 / 151510 (3.8%) | −261.0 | −258.1 | 2.83 |
| IRF3 SRX11453858 | Hep G2 Liver | 317 / 15151 (2.1%) | 71 / 151510 (0.0%) | −255.4 | −252.6 | 44.65 |
| Epitope tags DRX443510 | 293 Kidney | 1545 / 15151 (10.2%) | 5353 / 151510 (3.5%) | −252.7 | −249.9 | 2.89 |
| ING5 SRX286202 | RKO Digestive tract | 1391 / 15151 (9.2%) | 4578 / 151510 (3.0%) | −244.4 | −241.6 | 3.04 |
| TP53 SRX396254 | Fibroblasts Others | 969 / 15151 (6.4%) | 2385 / 151510 (1.6%) | −241.0 | −238.2 | 4.06 |
| TP53 SRX19538270 | U2OS Bone | 451 / 15151 (3.0%) | 381 / 151510 (0.3%) | −240.0 | −237.2 | 11.84 |
| 5-mC SRX882970 | LNCAP Prostate | 2738 / 15151 (18.1%) | 13655 / 151510 (9.0%) | −234.4 | −231.6 | 2.01 |
| AGO2 SRX6783957 | Hep G2 Liver | 1272 / 15151 (8.4%) | 4049 / 151510 (2.7%) | −233.3 | −230.5 | 3.14 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2020 / 15151 (13.3%) | 8688 / 151510 (5.7%) | −231.8 | −229.1 | 2.33 |
| AGO2 SRX6783958 | Hep G2 Liver | 1254 / 15151 (8.3%) | 3970 / 151510 (2.6%) | −231.6 | −228.8 | 3.16 |
| 5-mC SRX882968 | LNCAP Prostate | 2697 / 15151 (17.8%) | 13524 / 151510 (8.9%) | −227.4 | −224.6 | 1.99 |
| JADE3 DRX300415 | 293 Kidney | 1566 / 15151 (10.3%) | 5871 / 151510 (3.9%) | −226.4 | −223.6 | 2.67 |
| CIC SRX13262055 | Astrocytes Neural | 2878 / 15151 (19.0%) | 14906 / 151510 (9.8%) | −225.4 | −222.7 | 1.93 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 503 / 15151 (3.3%) | 592 / 151510 (0.4%) | −224.4 | −221.7 | 8.50 |
| FOXA1 SRX4815198 | MCF-7 Breast | 907 / 15151 (6.0%) | 21854 / 151510 (14.4%) | −219.1 | −216.4 | 0.42 |
| TP53 SRX19538271 | U2OS Bone | 644 / 15151 (4.3%) | 1129 / 151510 (0.7%) | −218.2 | −215.5 | 5.70 |
| FOXA1 SRX176862 | MCF-7 Breast | 308 / 15151 (2.0%) | 12420 / 151510 (8.2%) | −218.2 | −215.4 | 0.25 |
| FOXA1 SRX176863 | MCF-7 Breast | 287 / 15151 (1.9%) | 11934 / 151510 (7.9%) | −214.6 | −211.9 | 0.24 |
| IRF3 SRX11453861 | Hep G2 Liver | 273 / 15151 (1.8%) | 74 / 151510 (0.0%) | −211.5 | −208.8 | 36.89 |
| TP53 SRX19538282 | Osteoblasts Bone | 375 / 15151 (2.5%) | 280 / 151510 (0.2%) | −211.0 | −208.3 | 13.39 |
| FOXA1 SRX4815197 | MCF-7 Breast | 661 / 15151 (4.4%) | 17909 / 151510 (11.8%) | −209.9 | −207.2 | 0.37 |
| FOS SRX150477 | MCF 10A Breast | 646 / 15151 (4.3%) | 17609 / 151510 (11.6%) | −207.7 | −205.0 | 0.37 |
| BRD4 SRX736204 | 90-8TL Neural | 936 / 15151 (6.2%) | 2556 / 151510 (1.7%) | −206.9 | −204.2 | 3.66 |
| FOS SRX150478 | MCF 10A Breast | 682 / 15151 (4.5%) | 18006 / 151510 (11.9%) | −203.5 | −200.8 | 0.38 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1359 / 15151 (9.0%) | 4979 / 151510 (3.3%) | −202.4 | −199.8 | 2.73 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1417 / 15151 (9.4%) | 5356 / 151510 (3.5%) | −201.0 | −198.4 | 2.65 |
| Epitope tags SRX10549778 | K-562 Blood | 1113 / 15151 (7.3%) | 3599 / 151510 (2.4%) | −198.7 | −196.1 | 3.09 |
| 5-mC SRX882965 | LNCAP Prostate | 2186 / 15151 (14.4%) | 10534 / 151510 (7.0%) | −198.1 | −195.4 | 2.08 |
| STAT1 SRX23678708 | K-562 Blood | 1503 / 15151 (9.9%) | 5940 / 151510 (3.9%) | −197.9 | −195.3 | 2.53 |
| FOXA1 SRX1161177 | MCF-7 Breast | 252 / 15151 (1.7%) | 10733 / 151510 (7.1%) | −195.8 | −193.1 | 0.23 |
| EP300 ERX626821 | U-937 Blood | 1220 / 15151 (8.1%) | 4294 / 151510 (2.8%) | −192.9 | −190.3 | 2.84 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 628 / 15151 (4.1%) | 16763 / 151510 (11.1%) | −191.3 | −188.6 | 0.37 |
| MEN1 SRX11712604 | K-562 Blood | 1375 / 15151 (9.1%) | 5289 / 151510 (3.5%) | −189.1 | −186.5 | 2.60 |
| EP300 ERX626811 | U-937 Blood | 1209 / 15151 (8.0%) | 4289 / 151510 (2.8%) | −188.7 | −186.0 | 2.82 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1105 / 15151 (7.3%) | 3697 / 151510 (2.4%) | −187.8 | −185.2 | 2.99 |
| STAT1 SRX23678707 | K-562 Blood | 1393 / 15151 (9.2%) | 5426 / 151510 (3.6%) | −187.5 | −184.9 | 2.57 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 191 / 15151 (1.3%) | 9328 / 151510 (6.2%) | −187.3 | −184.7 | 0.20 |
| AR SRX10820653 | LNCAP Prostate | 309 / 15151 (2.0%) | 194 / 151510 (0.1%) | −186.7 | −184.1 | 15.93 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 473 / 15151 (3.1%) | 674 / 151510 (0.4%) | −186.6 | −184.0 | 7.02 |
| GATA3 SRX190239 | MCF-7 Breast | 415 / 15151 (2.7%) | 13256 / 151510 (8.7%) | −186.4 | −183.8 | 0.31 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 266 / 15151 (1.8%) | 108 / 151510 (0.1%) | −186.0 | −183.5 | 24.63 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1296 / 15151 (8.6%) | 4865 / 151510 (3.2%) | −185.2 | −182.7 | 2.66 |
| TLE3 SRX4815191 | MCF-7 Breast | 256 / 15151 (1.7%) | 10479 / 151510 (6.9%) | −184.9 | −182.3 | 0.24 |
| KAT7 DRX234808 | 293 Kidney | 778 / 15151 (5.1%) | 1995 / 151510 (1.3%) | −184.2 | −181.6 | 3.90 |
| FOXA1 SRX1161173 | MCF-7 Breast | 199 / 15151 (1.3%) | 9375 / 151510 (6.2%) | −183.7 | −181.1 | 0.21 |
| ESR1 SRX371478 | MCF-7 Breast | 358 / 15151 (2.4%) | 12198 / 151510 (8.1%) | −182.9 | −180.4 | 0.29 |
| ESR1 SRX20282961 | MCF-7 Breast | 354 / 15151 (2.3%) | 12119 / 151510 (8.0%) | −182.6 | −180.1 | 0.29 |
| FOXA1 SRX371483 | MCF-7 Breast | 311 / 15151 (2.1%) | 11361 / 151510 (7.5%) | −181.9 | −179.3 | 0.27 |
| FOXA1 SRX3931044 | MCF-7 Breast | 635 / 15151 (4.2%) | 16520 / 151510 (10.9%) | −181.5 | −178.9 | 0.38 |
| TRP47 SRX4548329 | THP-1 Blood | 2392 / 15151 (15.8%) | 12438 / 151510 (8.2%) | −181.1 | −178.6 | 1.92 |
| ESR1 SRX371469 | MCF-7 Breast | 288 / 15151 (1.9%) | 10891 / 151510 (7.2%) | −179.6 | −177.1 | 0.26 |
| JADE3 DRX234809 | 293 Kidney | 999 / 15151 (6.6%) | 3215 / 151510 (2.1%) | −179.0 | −176.5 | 3.11 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1610 / 15151 (10.6%) | 6984 / 151510 (4.6%) | −178.7 | −176.2 | 2.31 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1466 / 15151 (9.7%) | 6045 / 151510 (4.0%) | −178.5 | −176.0 | 2.43 |
| ESR1 SRX7624157 | MCF-7 Breast | 768 / 15151 (5.1%) | 18318 / 151510 (12.1%) | −177.3 | −174.8 | 0.42 |
| YAP1 SRX757325 | H2052 Lung | 770 / 15151 (5.1%) | 18341 / 151510 (12.1%) | −177.1 | −174.6 | 0.42 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1519 / 15151 (10.0%) | 6423 / 151510 (4.2%) | −176.7 | −174.2 | 2.36 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1628 / 15151 (10.7%) | 7143 / 151510 (4.7%) | −176.7 | −174.2 | 2.28 |
| FOS SRX4192880 | MCF 10A Breast | 498 / 15151 (3.3%) | 14248 / 151510 (9.4%) | −176.3 | −173.8 | 0.35 |
| FOXA1 SRX371481 | MCF-7 Breast | 299 / 15151 (2.0%) | 10963 / 151510 (7.2%) | −175.8 | −173.4 | 0.27 |
| LEO1 SRX1873456 | SEM Blood | 1369 / 15151 (9.0%) | 5487 / 151510 (3.6%) | −175.1 | −172.6 | 2.49 |
| FOXA1 SRX1161175 | MCF-7 Breast | 196 / 15151 (1.3%) | 9045 / 151510 (6.0%) | −174.3 | −171.8 | 0.22 |
| ESR1 SRX7624156 | MCF-7 Breast | 469 / 15151 (3.1%) | 13718 / 151510 (9.1%) | −174.2 | −171.7 | 0.34 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 345 / 15151 (2.3%) | 11644 / 151510 (7.7%) | −172.5 | −170.0 | 0.30 |
| FOXA1 SRX1161176 | MCF-7 Breast | 271 / 15151 (1.8%) | 10346 / 151510 (6.8%) | −171.8 | −169.3 | 0.26 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1512 / 15151 (10.0%) | 6481 / 151510 (4.3%) | −171.2 | −168.7 | 2.33 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 341 / 15151 (2.3%) | 11530 / 151510 (7.6%) | −171.0 | −168.5 | 0.30 |
| AR SRX1067071 | LHSAR Prostate | 598 / 15151 (3.9%) | 15582 / 151510 (10.3%) | −170.7 | −168.3 | 0.38 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1039 / 15151 (6.9%) | 3557 / 151510 (2.3%) | −170.3 | −167.9 | 2.92 |
| ESR1 SRX371476 | MCF-7 Breast | 202 / 15151 (1.3%) | 9035 / 151510 (6.0%) | −170.0 | −167.6 | 0.22 |
| CXXC1 SRX1424886 | SEM Blood | 1363 / 15151 (9.0%) | 5561 / 151510 (3.7%) | −168.7 | −166.3 | 2.45 |
| FOXA1 SRX371482 | MCF-7 Breast | 441 / 15151 (2.9%) | 13082 / 151510 (8.6%) | −168.5 | −166.1 | 0.34 |
| AR SRX10820651 | LNCAP Prostate | 325 / 15151 (2.1%) | 292 / 151510 (0.2%) | −167.8 | −165.3 | 11.13 |
| ING2 SRX286201 | RKO Digestive tract | 1334 / 15151 (8.8%) | 5395 / 151510 (3.6%) | −167.6 | −165.2 | 2.47 |
| ESR1 SRX176860 | MCF-7 Breast | 507 / 15151 (3.3%) | 13998 / 151510 (9.2%) | −165.1 | −162.7 | 0.36 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1663 / 15151 (11.0%) | 7621 / 151510 (5.0%) | −164.9 | −162.5 | 2.18 |
| FOXA1 SRX371480 | MCF-7 Breast | 188 / 15151 (1.2%) | 8613 / 151510 (5.7%) | −164.8 | −162.3 | 0.22 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 755 / 15151 (5.0%) | 2080 / 151510 (1.4%) | −164.4 | −162.0 | 3.63 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 647 / 15151 (4.3%) | 1551 / 151510 (1.0%) | −164.3 | −161.9 | 4.17 |
| Epitope tags SRX10549777 | K-562 Blood | 2238 / 15151 (14.8%) | 11744 / 151510 (7.8%) | −164.2 | −161.8 | 1.91 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 441 / 15151 (2.9%) | 12930 / 151510 (8.5%) | −164.1 | −161.7 | 0.34 |
| ESR1 SRX20282960 | MCF-7 Breast | 344 / 15151 (2.3%) | 11334 / 151510 (7.5%) | −163.4 | −161.0 | 0.30 |
| KAT6A SRX20971022 | Fibroblasts Others | 229 / 15151 (1.5%) | 87 / 151510 (0.1%) | −163.2 | −160.8 | 26.32 |
| TP53 SRX19538272 | U2OS Bone | 532 / 15151 (3.5%) | 1050 / 151510 (0.7%) | −162.8 | −160.4 | 5.07 |
| ESR1 SRX4367193 | MCF-7 Breast | 1013 / 15151 (6.7%) | 21159 / 151510 (14.0%) | −162.7 | −160.3 | 0.48 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 274 / 15151 (1.8%) | 10111 / 151510 (6.7%) | −162.6 | −160.2 | 0.27 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 582 / 15151 (3.8%) | 1269 / 151510 (0.8%) | −162.5 | −160.1 | 4.59 |
| ESR1 SRX371471 | ZR-75-1 Breast | 332 / 15151 (2.2%) | 11101 / 151510 (7.3%) | −162.4 | −160.0 | 0.30 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1146 / 15151 (7.6%) | 4311 / 151510 (2.8%) | −162.4 | −160.0 | 2.66 |
| FOS SRX150517 | MCF 10A Breast | 531 / 15151 (3.5%) | 14271 / 151510 (9.4%) | −162.4 | −160.0 | 0.37 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1155 / 15151 (7.6%) | 4370 / 151510 (2.9%) | −162.1 | −159.7 | 2.64 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 290 / 15151 (1.9%) | 10362 / 151510 (6.8%) | −161.6 | −159.2 | 0.28 |
| ESR1 SRX371470 | ZR-75-1 Breast | 276 / 15151 (1.8%) | 10096 / 151510 (6.7%) | −161.0 | −158.7 | 0.27 |
| SREBF2 SRX5359048 | HCC70 Breast | 1533 / 15151 (10.1%) | 6845 / 151510 (4.5%) | −159.8 | −157.5 | 2.24 |
| GATA3 SRX176864 | MCF-7 Breast | 214 / 15151 (1.4%) | 8949 / 151510 (5.9%) | −159.8 | −157.4 | 0.24 |
| ESR1 SRX1531791 | MCF-7 Breast | 293 / 15151 (1.9%) | 10341 / 151510 (6.8%) | −159.5 | −157.1 | 0.28 |
| ESR1 SRX176861 | MCF-7 Breast | 520 / 15151 (3.4%) | 13991 / 151510 (9.2%) | −159.3 | −156.9 | 0.37 |
| ESR1 SRX371479 | MCF-7 Breast | 281 / 15151 (1.9%) | 10127 / 151510 (6.7%) | −159.2 | −156.8 | 0.28 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1147 / 15151 (7.6%) | 4376 / 151510 (2.9%) | −158.7 | −156.3 | 2.62 |
| RBFOX2 SRX4708082 | K-562 Blood | 2135 / 15151 (14.1%) | 11160 / 151510 (7.4%) | −157.7 | −155.3 | 1.91 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 226 / 15151 (1.5%) | 9097 / 151510 (6.0%) | −157.4 | −155.1 | 0.25 |
| ESR1 SRX20282939 | MCF-7 Breast | 357 / 15151 (2.4%) | 11341 / 151510 (7.5%) | −157.2 | −154.8 | 0.31 |
| MYC SRX13134693 | 293 Kidney | 1216 / 15151 (8.0%) | 4845 / 151510 (3.2%) | −156.4 | −154.0 | 2.51 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 549 / 15151 (3.6%) | 14321 / 151510 (9.5%) | −156.2 | −153.9 | 0.38 |
| FOXA1 SRX1787653 | MCF-7 Breast | 240 / 15151 (1.6%) | 9309 / 151510 (6.1%) | −156.2 | −153.8 | 0.26 |
| BMI1 SRX7196721 | SF8628 Neural | 1550 / 15151 (10.2%) | 7052 / 151510 (4.7%) | −155.5 | −153.2 | 2.20 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1478 / 15151 (9.8%) | 6565 / 151510 (4.3%) | −155.4 | −153.1 | 2.25 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 276 / 15151 (1.8%) | 9904 / 151510 (6.5%) | −154.9 | −152.5 | 0.28 |
| YAP1 SRX757326 | H2052 Lung | 686 / 15151 (4.5%) | 16278 / 151510 (10.7%) | −154.6 | −152.3 | 0.42 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 470 / 15151 (3.1%) | 13050 / 151510 (8.6%) | −154.4 | −152.1 | 0.36 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1428 / 15151 (9.4%) | 6258 / 151510 (4.1%) | −154.2 | −151.9 | 2.28 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 282 / 15151 (1.9%) | 9983 / 151510 (6.6%) | −154.0 | −151.7 | 0.28 |
| GATA3 SRX5057632 | MCF-7 Breast | 194 / 15151 (1.3%) | 8399 / 151510 (5.5%) | −153.8 | −151.5 | 0.23 |
| MITF SRX1555436 | 501A Epidermis | 1757 / 15151 (11.6%) | 8538 / 151510 (5.6%) | −153.2 | −150.9 | 2.06 |
| FOXA1 SRX11222437 | MCF-7 Breast | 213 / 15151 (1.4%) | 8709 / 151510 (5.7%) | −152.4 | −150.1 | 0.24 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1721 / 15151 (11.4%) | 8312 / 151510 (5.5%) | −152.1 | −149.8 | 2.07 |
| AR SRX1067067 | LHSAR Prostate | 543 / 15151 (3.6%) | 14072 / 151510 (9.3%) | −151.9 | −149.6 | 0.39 |
| RAC1 SRX10365541 | MCF-7 Breast | 155 / 15151 (1.0%) | 7581 / 151510 (5.0%) | −151.4 | −149.1 | 0.20 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 213 / 15151 (1.4%) | 8672 / 151510 (5.7%) | −151.2 | −148.9 | 0.25 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 567 / 15151 (3.7%) | 1295 / 151510 (0.9%) | −151.2 | −148.9 | 4.38 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1347 / 15151 (8.9%) | 5792 / 151510 (3.8%) | −150.7 | −148.4 | 2.33 |
| FOXA1 SRX100454 | T-47D Breast | 423 / 15151 (2.8%) | 12181 / 151510 (8.0%) | −150.6 | −148.3 | 0.35 |
| ARID1A SRX5089376 | MCF-7 Breast | 270 / 15151 (1.8%) | 9663 / 151510 (6.4%) | −150.6 | −148.3 | 0.28 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 806 / 15151 (5.3%) | 2512 / 151510 (1.7%) | −150.2 | −147.9 | 3.21 |
| STAT5B SRX831881 | CD8+ T cells Blood | 237 / 15151 (1.6%) | 131 / 151510 (0.1%) | −150.2 | −147.9 | 18.09 |
| ESR1 SRX194569 | MCF-7 Breast | 340 / 15151 (2.2%) | 10827 / 151510 (7.1%) | −150.0 | −147.7 | 0.31 |
| AR SRX1067070 | LHSAR Prostate | 801 / 15151 (5.3%) | 17727 / 151510 (11.7%) | −149.9 | −147.6 | 0.45 |
| ESR1 SRX371467 | MCF-7 Breast | 341 / 15151 (2.3%) | 10826 / 151510 (7.1%) | −149.6 | −147.3 | 0.31 |
| TLE3 SRX4815192 | MCF-7 Breast | 281 / 15151 (1.9%) | 9818 / 151510 (6.5%) | −149.4 | −147.2 | 0.29 |
| KAT7 DRX300414 | 293 Kidney | 589 / 15151 (3.9%) | 1414 / 151510 (0.9%) | −149.2 | −147.0 | 4.17 |
| FOXA1 SRX1161174 | MCF-7 Breast | 327 / 15151 (2.2%) | 10581 / 151510 (7.0%) | −149.1 | −146.9 | 0.31 |
| ESR1 SRX20282954 | MCF-7 Breast | 352 / 15151 (2.3%) | 10990 / 151510 (7.3%) | −149.1 | −146.8 | 0.32 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1856 / 15151 (12.3%) | 9350 / 151510 (6.2%) | −148.9 | −146.6 | 1.99 |
| ESR1 SRX2943591 | MCF-7 Breast | 213 / 15151 (1.4%) | 8589 / 151510 (5.7%) | −148.5 | −146.3 | 0.25 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 720 / 15151 (4.8%) | 16532 / 151510 (10.9%) | −148.5 | −146.2 | 0.44 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 465 / 15151 (3.1%) | 879 / 151510 (0.6%) | −147.6 | −145.4 | 5.29 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 415 / 15151 (2.7%) | 11948 / 151510 (7.9%) | −147.5 | −145.3 | 0.35 |
| ESR1 SRX194572 | MCF-7 Breast | 197 / 15151 (1.3%) | 8262 / 151510 (5.5%) | −147.4 | −145.1 | 0.24 |
| ZFX SRX7805372 | 293 Kidney | 1396 / 15151 (9.2%) | 6182 / 151510 (4.1%) | −147.3 | −145.0 | 2.26 |
| FOXA1 SRX1787651 | MCF-7 Breast | 165 / 15151 (1.1%) | 7651 / 151510 (5.0%) | −147.2 | −144.9 | 0.22 |
| FOS SRX150476 | MCF 10A Breast | 572 / 15151 (3.8%) | 14326 / 151510 (9.5%) | −147.0 | −144.7 | 0.40 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1407 / 15151 (9.3%) | 6273 / 151510 (4.1%) | −146.5 | −144.2 | 2.24 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 324 / 15151 (2.1%) | 10439 / 151510 (6.9%) | −146.4 | −144.1 | 0.31 |
| ESR1 SRX10365536 | MCF-7 Breast | 161 / 15151 (1.1%) | 7539 / 151510 (5.0%) | −146.0 | −143.8 | 0.21 |
| AR SRX1067066 | LHSAR Prostate | 694 / 15151 (4.6%) | 16058 / 151510 (10.6%) | −145.9 | −143.7 | 0.43 |
| ZNF711 SRX7805363 | 293 Kidney | 1390 / 15151 (9.2%) | 6175 / 151510 (4.1%) | −145.8 | −143.5 | 2.25 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 429 / 15151 (2.8%) | 12085 / 151510 (8.0%) | −145.1 | −142.8 | 0.35 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 776 / 15151 (5.1%) | 17185 / 151510 (11.3%) | −145.0 | −142.8 | 0.45 |
| ESR1 SRX371468 | MCF-7 Breast | 204 / 15151 (1.3%) | 8316 / 151510 (5.5%) | −144.9 | −142.7 | 0.25 |
| FOXA1 SRX028634 | MCF-7 Breast | 141 / 15151 (0.9%) | 7117 / 151510 (4.7%) | −144.9 | −142.6 | 0.20 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 255 / 15151 (1.7%) | 9213 / 151510 (6.1%) | −144.7 | −142.5 | 0.28 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1612 / 15151 (10.6%) | 7722 / 151510 (5.1%) | −144.6 | −142.3 | 2.09 |
| RUNX1 SRX2014504 | Jurkat Blood | 2132 / 15151 (14.1%) | 11499 / 151510 (7.6%) | −144.5 | −142.3 | 1.85 |
| FOXA1 SRX3923514 | MCF-7 Breast | 329 / 15151 (2.2%) | 10458 / 151510 (6.9%) | −144.5 | −142.2 | 0.31 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1199 / 15151 (7.9%) | 22840 / 151510 (15.1%) | −144.2 | −142.0 | 0.52 |
| FOXA1 SRX11222441 | MCF-7 Breast | 244 / 15151 (1.6%) | 9001 / 151510 (5.9%) | −144.0 | −141.8 | 0.27 |
| ESR1 SRX20282972 | MCF-7 Breast | 371 / 15151 (2.4%) | 11093 / 151510 (7.3%) | −143.1 | −140.8 | 0.33 |
| FOXA1 SRX1787652 | MCF-7 Breast | 186 / 15151 (1.2%) | 7900 / 151510 (5.2%) | −142.2 | −140.0 | 0.24 |
| FOXA1 SRX1787655 | MCF-7 Breast | 148 / 15151 (1.0%) | 7169 / 151510 (4.7%) | −141.9 | −139.7 | 0.21 |
| AR SRX9469988 | LAPC-4 Prostate | 451 / 15151 (3.0%) | 12309 / 151510 (8.1%) | −141.8 | −139.6 | 0.37 |
| FOXA1 SRX5323843 | MCF-7 Breast | 153 / 15151 (1.0%) | 7258 / 151510 (4.8%) | −141.7 | −139.5 | 0.21 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1490 / 15151 (9.8%) | 6942 / 151510 (4.6%) | −141.6 | −139.4 | 2.15 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 554 / 15151 (3.7%) | 13842 / 151510 (9.1%) | −141.2 | −139.0 | 0.40 |
| RAC1 SRX10365543 | MCF-7 Breast | 169 / 15151 (1.1%) | 7548 / 151510 (5.0%) | −141.2 | −139.0 | 0.22 |
| FOXA1 SRX5203303 | MCF-7 Breast | 91 / 15151 (0.6%) | 5966 / 151510 (3.9%) | −141.0 | −138.8 | 0.15 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1665 / 15151 (11.0%) | 8183 / 151510 (5.4%) | −140.8 | −138.6 | 2.03 |
| ESR1 SRX371477 | MCF-7 Breast | 150 / 15151 (1.0%) | 7172 / 151510 (4.7%) | −140.8 | −138.6 | 0.21 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1104 / 15151 (7.3%) | 4419 / 151510 (2.9%) | −140.2 | −138.0 | 2.50 |
| ZNF711 SRX7805362 | 293 Kidney | 1309 / 15151 (8.6%) | 5753 / 151510 (3.8%) | −139.9 | −137.7 | 2.28 |
| YAP1 SRX5718140 | 293 Kidney | 584 / 15151 (3.9%) | 14220 / 151510 (9.4%) | −139.4 | −137.2 | 0.41 |
| FOXA2 SRX100448 | Hep G2 Liver | 374 / 15151 (2.5%) | 10996 / 151510 (7.3%) | −138.8 | −136.6 | 0.34 |
| JUNB SRX8488088 | SUM 229PE Breast | 653 / 15151 (4.3%) | 15182 / 151510 (10.0%) | −138.4 | −136.2 | 0.43 |
| FOXA1 SRX3931043 | MCF-7 Breast | 347 / 15151 (2.3%) | 10516 / 151510 (6.9%) | −137.5 | −135.3 | 0.33 |
| ESR1 SRX10365535 | MCF-7 Breast | 272 / 15151 (1.8%) | 9273 / 151510 (6.1%) | −137.4 | −135.2 | 0.29 |
| MECOM SRX23677884 | HNT-34 Blood | 1520 / 15151 (10.0%) | 7242 / 151510 (4.8%) | −137.4 | −135.2 | 2.10 |
| FOXA1 SRX028635 | MCF-7 Breast | 154 / 15151 (1.0%) | 7137 / 151510 (4.7%) | −137.0 | −134.9 | 0.22 |
| ESR1 SRX20282946 | MCF-7 Breast | 191 / 15151 (1.3%) | 7818 / 151510 (5.2%) | −136.6 | −134.4 | 0.24 |
| FOXA1 SRX3923517 | MCF-7 Breast | 233 / 15151 (1.5%) | 8571 / 151510 (5.7%) | −136.5 | −134.3 | 0.27 |
| FOXA1 SRX11222442 | MCF-7 Breast | 219 / 15151 (1.4%) | 8319 / 151510 (5.5%) | −136.3 | −134.2 | 0.26 |
| SMARCA2 SRX8119677 | MeT-5A Others | 555 / 15151 (3.7%) | 13672 / 151510 (9.0%) | −136.2 | −134.1 | 0.41 |
| MECOM SRX23677896 | HNT-34 Blood | 1856 / 15151 (12.3%) | 9681 / 151510 (6.4%) | −136.1 | −133.9 | 1.92 |
| FOS SRX4192879 | MCF 10A Breast | 393 / 15151 (2.6%) | 11194 / 151510 (7.4%) | −135.9 | −133.7 | 0.35 |
| CHD1 SRX186771 | K-562 Blood | 645 / 15151 (4.3%) | 1824 / 151510 (1.2%) | −135.8 | −133.6 | 3.54 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 456 / 15151 (3.0%) | 12158 / 151510 (8.0%) | −135.5 | −133.4 | 0.38 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 152 / 15151 (1.0%) | 7051 / 151510 (4.7%) | −135.4 | −133.2 | 0.22 |
| FOXA2 SRX3230382 | Hep G2 Liver | 475 / 15151 (3.1%) | 12439 / 151510 (8.2%) | −135.2 | −133.1 | 0.38 |
| FOXA1 SRX3931054 | MCF-7 Breast | 322 / 15151 (2.1%) | 10029 / 151510 (6.6%) | −135.1 | −132.9 | 0.32 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 783 / 15151 (5.2%) | 2578 / 151510 (1.7%) | −135.0 | −132.9 | 3.04 |
| FOXA1 SRX3931055 | MCF-7 Breast | 288 / 15151 (1.9%) | 9445 / 151510 (6.2%) | −134.4 | −132.2 | 0.30 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 714 / 15151 (4.7%) | 2206 / 151510 (1.5%) | −134.3 | −132.2 | 3.24 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 318 / 15151 (2.1%) | 9940 / 151510 (6.6%) | −134.3 | −132.2 | 0.32 |
| ESR1 SRX10365532 | MCF-7 Breast | 177 / 15151 (1.2%) | 7491 / 151510 (4.9%) | −134.3 | −132.2 | 0.24 |
| ESR1 SRX2943589 | MCF-7 Breast | 164 / 15151 (1.1%) | 7247 / 151510 (4.8%) | −134.3 | −132.2 | 0.23 |
| MECOM SRX23677885 | HNT-34 Blood | 1530 / 15151 (10.1%) | 7396 / 151510 (4.9%) | −133.8 | −131.7 | 2.07 |
| GATA3 SRX6712581 | MCF-7 Breast | 279 / 15151 (1.8%) | 9270 / 151510 (6.1%) | −133.6 | −131.5 | 0.30 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 826 / 15151 (5.5%) | 17409 / 151510 (11.5%) | −133.6 | −131.5 | 0.47 |
| ESR1 SRX20282973 | MCF-7 Breast | 417 / 15151 (2.8%) | 11486 / 151510 (7.6%) | −133.5 | −131.4 | 0.36 |
| ESR1 SRX10365533 | MCF-7 Breast | 153 / 15151 (1.0%) | 7014 / 151510 (4.6%) | −133.5 | −131.3 | 0.22 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1315 / 15151 (8.7%) | 23833 / 151510 (15.7%) | −133.2 | −131.1 | 0.55 |
| MECOM SRX23677897 | HNT-34 Blood | 1784 / 15151 (11.8%) | 9230 / 151510 (6.1%) | −133.2 | −131.1 | 1.93 |
| INTS3 SRX3640569 | HeLa Uterus | 1118 / 15151 (7.4%) | 4635 / 151510 (3.1%) | −133.1 | −131.0 | 2.41 |
| CEBPB SRX150632 | HeLa Uterus | 781 / 15151 (5.2%) | 16767 / 151510 (11.1%) | −133.1 | −131.0 | 0.47 |
| NABP2 SRX9523535 | HT-1080 Bone | 1204 / 15151 (7.9%) | 5208 / 151510 (3.4%) | −132.3 | −130.2 | 2.31 |
| KDM5A SRX23740430 | SUM 149PT Breast | 1460 / 15151 (9.6%) | 6944 / 151510 (4.6%) | −132.3 | −130.2 | 2.10 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 674 / 15151 (4.4%) | 2018 / 151510 (1.3%) | −132.1 | −130.0 | 3.34 |
| FOXA1 SRX3923516 | MCF-7 Breast | 242 / 15151 (1.6%) | 8581 / 151510 (5.7%) | −131.9 | −129.8 | 0.28 |
| ESR1 SRX20282940 | MCF-7 Breast | 379 / 15151 (2.5%) | 10836 / 151510 (7.2%) | −131.9 | −129.7 | 0.35 |
| ETS1 SRX9046311 | THP-1 Blood | 973 / 15151 (6.4%) | 3750 / 151510 (2.5%) | −131.6 | −129.5 | 2.59 |
| FOXA1 SRX100506 | Hep G2 Liver | 468 / 15151 (3.1%) | 12200 / 151510 (8.1%) | −131.6 | −129.5 | 0.38 |
| FOXA1 SRX11222438 | MCF-7 Breast | 178 / 15151 (1.2%) | 7398 / 151510 (4.9%) | −130.6 | −128.5 | 0.24 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 315 / 15151 (2.1%) | 9758 / 151510 (6.4%) | −130.5 | −128.4 | 0.32 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 243 / 15151 (1.6%) | 8551 / 151510 (5.6%) | −130.4 | −128.3 | 0.28 |
| ARID1A SRX5089379 | MCF-7 Breast | 347 / 15151 (2.3%) | 10272 / 151510 (6.8%) | −130.4 | −128.3 | 0.34 |
| ESR1 SRX330070 | MCF-7 Breast | 168 / 15151 (1.1%) | 7204 / 151510 (4.8%) | −130.4 | −128.2 | 0.23 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1638 / 15151 (10.8%) | 8251 / 151510 (5.4%) | −130.3 | −128.2 | 1.99 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 709 / 15151 (4.7%) | 2233 / 151510 (1.5%) | −130.0 | −127.9 | 3.18 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1660 / 15151 (11.0%) | 8420 / 151510 (5.6%) | −129.8 | −127.7 | 1.97 |
| FOXA1 SRX3923519 | MCF-7 Breast | 207 / 15151 (1.4%) | 7894 / 151510 (5.2%) | −129.7 | −127.6 | 0.26 |
| ESR1 SRX330069 | MCF-7 Breast | 205 / 15151 (1.4%) | 7856 / 151510 (5.2%) | −129.6 | −127.5 | 0.26 |
| FOXA1 SRX1447317 | MCF-7 Breast | 222 / 15151 (1.5%) | 8159 / 151510 (5.4%) | −129.6 | −127.5 | 0.27 |
| PGR SRX1012655 | MCF-7 Breast | 216 / 15151 (1.4%) | 8049 / 151510 (5.3%) | −129.5 | −127.4 | 0.27 |
| MEN1 SRX14030481 | MV-4-11 Blood | 792 / 15151 (5.2%) | 2707 / 151510 (1.8%) | −129.3 | −127.3 | 2.93 |
| ESR1 SRX20282955 | MCF-7 Breast | 373 / 15151 (2.5%) | 10645 / 151510 (7.0%) | −129.2 | −127.1 | 0.35 |
| CHD1 SRX116417 | K-562 Blood | 602 / 15151 (4.0%) | 1675 / 151510 (1.1%) | −129.2 | −127.1 | 3.59 |
| ESR1 SRX371474 | BT-474 Breast | 154 / 15151 (1.0%) | 6899 / 151510 (4.6%) | −129.0 | −126.9 | 0.22 |
| FOXA1 SRX5323845 | MCF-7 Breast | 116 / 15151 (0.8%) | 6148 / 151510 (4.1%) | −128.9 | −126.8 | 0.19 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 387 / 15151 (2.6%) | 10842 / 151510 (7.2%) | −128.5 | −126.4 | 0.36 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 332 / 15151 (2.2%) | 9967 / 151510 (6.6%) | −128.5 | −126.4 | 0.33 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 1193 / 15151 (7.9%) | 5212 / 151510 (3.4%) | −128.4 | −126.4 | 2.29 |
| FOXA1 SRX1161203 | T-47D Breast | 254 / 15151 (1.7%) | 8672 / 151510 (5.7%) | −128.3 | −126.2 | 0.29 |
| MED1 SRX13134691 | 293 Kidney | 979 / 15151 (6.5%) | 3851 / 151510 (2.5%) | −127.8 | −125.8 | 2.54 |
| ESR1 SRX371475 | BT-474 Breast | 173 / 15151 (1.1%) | 7210 / 151510 (4.8%) | −127.6 | −125.5 | 0.24 |
| FOXA1 SRX3923518 | MCF-7 Breast | 239 / 15151 (1.6%) | 8370 / 151510 (5.5%) | −127.0 | −125.0 | 0.29 |
| KDM5A SRX23740438 | SUM 149PT Breast | 1490 / 15151 (9.8%) | 7284 / 151510 (4.8%) | −126.7 | −124.7 | 2.05 |
| FOXA1 SRX5203294 | MCF-7 Breast | 88 / 15151 (0.6%) | 5497 / 151510 (3.6%) | −126.4 | −124.4 | 0.16 |
| ZFX SRX7805370 | 293 Kidney | 990 / 15151 (6.5%) | 3943 / 151510 (2.6%) | −126.4 | −124.4 | 2.51 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 638 / 15151 (4.2%) | 1894 / 151510 (1.3%) | −126.3 | −124.3 | 3.37 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 385 / 15151 (2.5%) | 10731 / 151510 (7.1%) | −126.3 | −124.2 | 0.36 |
| ESR1 SRX2912055 | MCF-7 Breast | 125 / 15151 (0.8%) | 6253 / 151510 (4.1%) | −126.2 | −124.2 | 0.20 |
| FOXA1 SRX15430999 | T-47D Breast | 397 / 15151 (2.6%) | 10914 / 151510 (7.2%) | −126.2 | −124.1 | 0.36 |
| MED1 SRX13134690 | 293 Kidney | 1034 / 15151 (6.8%) | 4225 / 151510 (2.8%) | −126.1 | −124.1 | 2.45 |
| GFP SRX20436833 | DLD-1 Digestive tract | 1280 / 15151 (8.4%) | 5845 / 151510 (3.9%) | −126.0 | −123.9 | 2.19 |
| ERG SRX063922 | K-562 Blood | 1341 / 15151 (8.9%) | 6277 / 151510 (4.1%) | −125.4 | −123.3 | 2.14 |
| CEBPA SRX2630241 | Hep G2 Liver | 444 / 15151 (2.9%) | 11607 / 151510 (7.7%) | −125.3 | −123.3 | 0.38 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 689 / 15151 (4.5%) | 15159 / 151510 (10.0%) | −125.1 | −123.1 | 0.45 |
| FOXA1 SRX1787654 | MCF-7 Breast | 120 / 15151 (0.8%) | 6115 / 151510 (4.0%) | −125.0 | −122.9 | 0.20 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 591 / 15151 (3.9%) | 1665 / 151510 (1.1%) | −124.9 | −122.8 | 3.55 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 462 / 15151 (3.0%) | 1040 / 151510 (0.7%) | −124.8 | −122.8 | 4.44 |
| FOXA1 SRX3923515 | MCF-7 Breast | 193 / 15151 (1.3%) | 7489 / 151510 (4.9%) | −124.8 | −122.7 | 0.26 |
| MBD3 SRX1674506 | HeLa Uterus | 2252 / 15151 (14.9%) | 13013 / 151510 (8.6%) | −124.8 | −122.7 | 1.73 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 332 / 15151 (2.2%) | 9835 / 151510 (6.5%) | −124.7 | −122.6 | 0.34 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 171 / 15151 (1.1%) | 7082 / 151510 (4.7%) | −124.6 | −122.6 | 0.24 |
| FOXA1 SRX3931033 | MCF-7 Breast | 226 / 15151 (1.5%) | 8067 / 151510 (5.3%) | −124.5 | −122.5 | 0.28 |
| FOXA1 SRX5203307 | MCF-7 Breast | 94 / 15151 (0.6%) | 5568 / 151510 (3.7%) | −124.5 | −122.5 | 0.17 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 291 / 15151 (1.9%) | 9162 / 151510 (6.0%) | −124.4 | −122.4 | 0.32 |
| ESR1 SRX1469949 | MCF-7 Breast | 197 / 15151 (1.3%) | 7548 / 151510 (5.0%) | −124.4 | −122.4 | 0.26 |
| ESR1 SRX3110725 | MCF-7 Breast | 319 / 15151 (2.1%) | 9602 / 151510 (6.3%) | −124.0 | −122.0 | 0.33 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 465 / 15151 (3.1%) | 11866 / 151510 (7.8%) | −123.8 | −121.8 | 0.39 |
| EP300 SRX176885 | MCF-7 Breast | 184 / 15151 (1.2%) | 7301 / 151510 (4.8%) | −123.8 | −121.8 | 0.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 731 / 15151 (4.8%) | 15691 / 151510 (10.4%) | −123.8 | −121.8 | 0.47 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1180 / 15151 (7.8%) | 21663 / 151510 (14.3%) | −123.8 | −121.7 | 0.54 |
| EP300 SRX2194266 | SUM 159PT Breast | 627 / 15151 (4.1%) | 14229 / 151510 (9.4%) | −123.8 | −121.7 | 0.44 |
| CTCF SRX12008351 | MCF 10A Breast | 2501 / 15151 (16.5%) | 15013 / 151510 (9.9%) | −123.6 | −121.6 | 1.67 |
| NR2F2 SRX190293 | MCF-7 Breast | 385 / 15151 (2.5%) | 10633 / 151510 (7.0%) | −123.6 | −121.6 | 0.36 |
| RBFOX2 SRX3322781 | K-562 Blood | 1721 / 15151 (11.4%) | 9032 / 151510 (6.0%) | −123.4 | −121.4 | 1.91 |
| FOXA1 SRX6878603 | LNCAP Prostate | 405 / 15151 (2.7%) | 10936 / 151510 (7.2%) | −123.3 | −121.3 | 0.37 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 806 / 15151 (5.3%) | 16701 / 151510 (11.0%) | −123.2 | −121.2 | 0.48 |
| Epitope tags SRX8030771 | 293 Kidney | 1388 / 15151 (9.2%) | 6653 / 151510 (4.4%) | −123.2 | −121.2 | 2.09 |
| ESR1 SRX2881000 | MCF-7 Breast | 317 / 15151 (2.1%) | 9535 / 151510 (6.3%) | −122.9 | −120.9 | 0.33 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1524 / 15151 (10.1%) | 7622 / 151510 (5.0%) | −122.8 | −120.8 | 2.00 |
| ESR1 SRX1012632 | MCF-7 Breast | 170 / 15151 (1.1%) | 7004 / 151510 (4.6%) | −122.6 | −120.6 | 0.24 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 940 / 15151 (6.2%) | 18477 / 151510 (12.2%) | −122.6 | −120.6 | 0.51 |
| JUN SRX17561461 | LPS141 Adipocyte | 525 / 15151 (3.5%) | 12707 / 151510 (8.4%) | −122.6 | −120.6 | 0.41 |
| FOXA1 SRX5323829 | T-47D Breast | 201 / 15151 (1.3%) | 7559 / 151510 (5.0%) | −122.4 | −120.4 | 0.27 |
| EP300 SRX1012648 | MCF-7 Breast | 167 / 15151 (1.1%) | 6942 / 151510 (4.6%) | −122.4 | −120.3 | 0.24 |
| CEBPB SRX2194250 | SUM 159PT Breast | 441 / 15151 (2.9%) | 11447 / 151510 (7.6%) | −122.4 | −120.3 | 0.39 |
| FOXA1 SRX5323846 | MCF-7 Breast | 128 / 15151 (0.8%) | 6201 / 151510 (4.1%) | −122.3 | −120.3 | 0.21 |
| SETD1A SRX23734380 | MOLM-13 Blood | 909 / 15151 (6.0%) | 3510 / 151510 (2.3%) | −122.3 | −120.3 | 2.59 |
| NANOG SRX10445309 | Neural crest cells Neural | 193 / 15151 (1.3%) | 7406 / 151510 (4.9%) | −122.1 | −120.1 | 0.26 |
| ESR1 SRX330067 | MCF-7 Breast | 330 / 15151 (2.2%) | 9715 / 151510 (6.4%) | −122.1 | −120.1 | 0.34 |
| MEN1 SRX14030471 | MV-4-11 Blood | 851 / 15151 (5.6%) | 3162 / 151510 (2.1%) | −122.1 | −120.1 | 2.69 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 318 / 15151 (2.1%) | 9517 / 151510 (6.3%) | −122.0 | −120.0 | 0.33 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 352 / 15151 (2.3%) | 10055 / 151510 (6.6%) | −121.9 | −119.9 | 0.35 |
| TEAD1 SRX3401272 | MCF-7 Breast | 282 / 15151 (1.9%) | 8919 / 151510 (5.9%) | −121.7 | −119.7 | 0.32 |
| FOXA1 SRX1961158 | T-47D Breast | 359 / 15151 (2.4%) | 10158 / 151510 (6.7%) | −121.6 | −119.6 | 0.35 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1064 / 15151 (7.0%) | 4507 / 151510 (3.0%) | −121.4 | −119.4 | 2.36 |
| ESR1 SRX3123829 | MCF-7 Breast | 205 / 15151 (1.4%) | 7594 / 151510 (5.0%) | −121.4 | −119.4 | 0.27 |
| KMT2A SRX5732680 | MOLM-13 Blood | 1152 / 15151 (7.6%) | 5085 / 151510 (3.4%) | −121.3 | −119.3 | 2.27 |
| KAT6A DRX366109 | 293 Kidney | 1768 / 15151 (11.7%) | 9441 / 151510 (6.2%) | −121.2 | −119.2 | 1.87 |
| BMI1 SRX644729 | 293 Kidney | 203 / 15151 (1.3%) | 132 / 151510 (0.1%) | −121.1 | −119.1 | 15.38 |
| ESR1 SRX4451213 | MCF-7 Breast | 373 / 15151 (2.5%) | 10356 / 151510 (6.8%) | −121.1 | −119.1 | 0.36 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 859 / 15151 (5.7%) | 17322 / 151510 (11.4%) | −121.0 | −119.0 | 0.50 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 839 / 15151 (5.5%) | 3107 / 151510 (2.1%) | −121.0 | −119.0 | 2.70 |
| ESR1 SRX20282971 | MCF-7 Breast | 362 / 15151 (2.4%) | 10178 / 151510 (6.7%) | −120.9 | −119.0 | 0.36 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 630 / 15151 (4.2%) | 14152 / 151510 (9.3%) | −120.7 | −118.7 | 0.45 |
| ARID1A SRX5089391 | MCF-7 Breast | 201 / 15151 (1.3%) | 7496 / 151510 (4.9%) | −120.4 | −118.4 | 0.27 |
| KMT2A SRX2281249 | SEM Blood | 1654 / 15151 (10.9%) | 8626 / 151510 (5.7%) | −120.3 | −118.4 | 1.92 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 248 / 15151 (1.6%) | 8301 / 151510 (5.5%) | −120.2 | −118.2 | 0.30 |
| KMT2A SRX8151116 | VDH-15 Others | 1459 / 15151 (9.6%) | 7225 / 151510 (4.8%) | −120.2 | −118.2 | 2.02 |
| ESR1 SRX2881002 | MCF-7 Breast | 351 / 15151 (2.3%) | 9972 / 151510 (6.6%) | −120.0 | −118.0 | 0.35 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 338 / 15151 (2.2%) | 9758 / 151510 (6.4%) | −119.8 | −117.8 | 0.35 |
| NFYB SRX16608147 | HeLa Uterus | 223 / 15151 (1.5%) | 185 / 151510 (0.1%) | −119.7 | −117.8 | 12.05 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 77 / 15151 (0.5%) | 5057 / 151510 (3.3%) | −119.4 | −117.4 | 0.15 |
| AR SRX1067068 | LHSAR Prostate | 436 / 15151 (2.9%) | 11258 / 151510 (7.4%) | −119.2 | −117.2 | 0.39 |
| KMT2A SRX2323891 | 293 Kidney | 832 / 15151 (5.5%) | 3092 / 151510 (2.0%) | −119.2 | −117.2 | 2.69 |
| KMT2A SRX2281247 | SEM Blood | 1387 / 15151 (9.2%) | 6740 / 151510 (4.4%) | −119.2 | −117.2 | 2.06 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 1103 / 15151 (7.3%) | 4806 / 151510 (3.2%) | −119.1 | −117.2 | 2.30 |
| KMT2A SRX8151120 | VDH-15 Others | 1782 / 15151 (11.8%) | 9603 / 151510 (6.3%) | −119.1 | −117.1 | 1.86 |
| ESR1 SRX8537722 | MCF-7 Breast | 341 / 15151 (2.3%) | 9777 / 151510 (6.5%) | −119.0 | −117.0 | 0.35 |
| AFF1 SRX2281250 | SEM Blood | 826 / 15151 (5.5%) | 3060 / 151510 (2.0%) | −118.9 | −116.9 | 2.70 |
| FOXA1 SRX1961157 | T-47D Breast | 402 / 15151 (2.7%) | 10724 / 151510 (7.1%) | −118.9 | −116.9 | 0.37 |
| KDM5A SRX23740439 | SUM 149PT Breast | 1439 / 15151 (9.5%) | 7116 / 151510 (4.7%) | −118.9 | −116.9 | 2.02 |
| SS18 SRX3468047 | Fibroblasts Others | 905 / 15151 (6.0%) | 17843 / 151510 (11.8%) | −118.8 | −116.8 | 0.51 |
| JUN SRX4192884 | MCF 10A Breast | 313 / 15151 (2.1%) | 9324 / 151510 (6.2%) | −118.8 | −116.8 | 0.34 |
| FOXA1 SRX1447316 | MCF-7 Breast | 154 / 15151 (1.0%) | 6590 / 151510 (4.3%) | −118.7 | −116.8 | 0.23 |
| ZFX SRX7805365 | 22Rv1 Prostate | 1170 / 15151 (7.7%) | 5263 / 151510 (3.5%) | −118.6 | −116.6 | 2.22 |
| ESR1 SRX10365558 | MCF-7 Breast | 253 / 15151 (1.7%) | 8325 / 151510 (5.5%) | −118.4 | −116.4 | 0.30 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 353 / 15151 (2.3%) | 9942 / 151510 (6.6%) | −118.3 | −116.3 | 0.36 |
| NR3C1 SRX17639412 | A549 Lung | 413 / 15151 (2.7%) | 10869 / 151510 (7.2%) | −118.2 | −116.2 | 0.38 |
| HDAC1 SRX17989500 | PBMC Blood | 1345 / 15151 (8.9%) | 6472 / 151510 (4.3%) | −118.1 | −116.1 | 2.08 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 174 / 15151 (1.1%) | 79 / 151510 (0.1%) | −117.9 | −115.9 | 22.03 |
| CDK9 SRX7366783 | MCF-7 Breast | 202 / 15151 (1.3%) | 139 / 151510 (0.1%) | −117.8 | −115.8 | 14.53 |
| KMT2A SRX8151118 | VDH-15 Others | 1717 / 15151 (11.3%) | 9163 / 151510 (6.0%) | −117.7 | −115.7 | 1.87 |
| KAT6A DRX366108 | 293 Kidney | 1459 / 15151 (9.6%) | 7290 / 151510 (4.8%) | −117.5 | −115.5 | 2.00 |
| GFP SRX12567758 | MRC-5 Lung | 1284 / 15151 (8.5%) | 6062 / 151510 (4.0%) | −117.5 | −115.5 | 2.12 |
| FOXA1 SRX100477 | Hep G2 Liver | 430 / 15151 (2.8%) | 11099 / 151510 (7.3%) | −117.5 | −115.5 | 0.39 |
| GATAD2A SRX2636506 | Hep G2 Liver | 482 / 15151 (3.2%) | 11879 / 151510 (7.8%) | −117.4 | −115.5 | 0.41 |
| ESR1 SRX1012629 | MCF-7 Breast | 231 / 15151 (1.5%) | 7915 / 151510 (5.2%) | −117.2 | −115.3 | 0.29 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 129 / 15151 (0.9%) | 6068 / 151510 (4.0%) | −117.2 | −115.3 | 0.21 |
| PROX1 SRX3230397 | Hep G2 Liver | 275 / 15151 (1.8%) | 8649 / 151510 (5.7%) | −117.2 | −115.2 | 0.32 |
| ZFX SRX3322295 | HCT 116 Digestive tract | 1139 / 15151 (7.5%) | 5088 / 151510 (3.4%) | −117.1 | −115.1 | 2.24 |
| TAF1 SRX11120885 | MCF-7 Breast | 1436 / 15151 (9.5%) | 7137 / 151510 (4.7%) | −117.0 | −115.1 | 2.01 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 360 / 15151 (2.4%) | 10003 / 151510 (6.6%) | −116.8 | −114.9 | 0.36 |
| FOXA1 SRX1161207 | T-47D Breast | 152 / 15151 (1.0%) | 6492 / 151510 (4.3%) | −116.8 | −114.9 | 0.23 |
| CEBPA SRX4705113 | MOLM-13 Blood | 844 / 15151 (5.6%) | 16937 / 151510 (11.2%) | −116.8 | −114.9 | 0.50 |
| FOXA1 SRX6860635 | T-47D Breast | 280 / 15151 (1.8%) | 8720 / 151510 (5.8%) | −116.8 | −114.8 | 0.32 |
| RBM22 SRX4708083 | K-562 Blood | 788 / 15151 (5.2%) | 2866 / 151510 (1.9%) | −116.8 | −114.8 | 2.75 |
| ESR1 SRX20282938 | MCF-7 Breast | 298 / 15151 (2.0%) | 9014 / 151510 (5.9%) | −116.8 | −114.8 | 0.33 |
| MethylCap SRX014767 | NB-4 Blood | 1454 / 15151 (9.6%) | 7273 / 151510 (4.8%) | −116.8 | −114.8 | 2.00 |
| ARID1A SRX5089385 | MCF-7 Breast | 281 / 15151 (1.9%) | 8737 / 151510 (5.8%) | −116.8 | −114.8 | 0.32 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 253 / 15151 (1.7%) | 8269 / 151510 (5.5%) | −116.7 | −114.8 | 0.31 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1078 / 15151 (7.1%) | 20007 / 151510 (13.2%) | −116.5 | −114.6 | 0.54 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 338 / 15151 (2.2%) | 9643 / 151510 (6.4%) | −116.5 | −114.5 | 0.35 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1425 / 15151 (9.4%) | 7077 / 151510 (4.7%) | −116.4 | −114.4 | 2.01 |
| SOX13 SRX2636248 | Hep G2 Liver | 519 / 15151 (3.4%) | 12375 / 151510 (8.2%) | −116.2 | −114.3 | 0.42 |
| FOXA1 SRX3931056 | MCF-7 Breast | 221 / 15151 (1.5%) | 7710 / 151510 (5.1%) | −116.2 | −114.3 | 0.29 |
| ESR1 SRX1531796 | MCF-7 Breast | 199 / 15151 (1.3%) | 7309 / 151510 (4.8%) | −115.7 | −113.8 | 0.27 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 104 / 15151 (0.7%) | 5522 / 151510 (3.6%) | −115.6 | −113.7 | 0.19 |
| SMARCA4 SRX5212366 | Mel270 Others | 501 / 15151 (3.3%) | 12088 / 151510 (8.0%) | −115.6 | −113.7 | 0.41 |
| ESR1 SRX20282953 | MCF-7 Breast | 309 / 15151 (2.0%) | 9139 / 151510 (6.0%) | −115.3 | −113.4 | 0.34 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1497 / 15151 (9.9%) | 7621 / 151510 (5.0%) | −115.3 | −113.3 | 1.96 |
| ERG SRX063921 | K-562 Blood | 1255 / 15151 (8.3%) | 5914 / 151510 (3.9%) | −115.3 | −113.3 | 2.12 |
| FOXA1 SRX3931032 | MCF-7 Breast | 218 / 15151 (1.4%) | 7618 / 151510 (5.0%) | −115.0 | −113.1 | 0.29 |
| NR3C1 SRX19024866 | MCF-7 Breast | 127 / 15151 (0.8%) | 5960 / 151510 (3.9%) | −115.0 | −113.1 | 0.21 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1388 / 15151 (9.2%) | 6849 / 151510 (4.5%) | −114.9 | −113.0 | 2.03 |
| JUNB SRX8488073 | SUM 229PE Breast | 694 / 15151 (4.6%) | 14807 / 151510 (9.8%) | −114.9 | −113.0 | 0.47 |
| FOXA1 SRX5323830 | T-47D Breast | 226 / 15151 (1.5%) | 7747 / 151510 (5.1%) | −114.7 | −112.8 | 0.29 |
| ESR1 SRX792933 | LY2 Breast | 314 / 15151 (2.1%) | 9194 / 151510 (6.1%) | −114.6 | −112.7 | 0.34 |
| ESR1 SRX20282959 | MCF-7 Breast | 154 / 15151 (1.0%) | 6460 / 151510 (4.3%) | −114.6 | −112.7 | 0.24 |
| MECOM SRX23677890 | HNT-34 Blood | 1513 / 15151 (10.0%) | 7757 / 151510 (5.1%) | −114.4 | −112.5 | 1.95 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 252 / 15151 (1.7%) | 8175 / 151510 (5.4%) | −114.4 | −112.4 | 0.31 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 1311 / 15151 (8.7%) | 6323 / 151510 (4.2%) | −114.3 | −112.4 | 2.07 |
| JUNB SRX10119386 | MCF 10A Breast | 343 / 15151 (2.3%) | 9639 / 151510 (6.4%) | −114.2 | −112.3 | 0.36 |
| RBFOX2 SRX3322782 | K-562 Blood | 1599 / 15151 (10.6%) | 8391 / 151510 (5.5%) | −114.1 | −112.2 | 1.91 |
| KMT2A SRX8151119 | VDH-15 Others | 1626 / 15151 (10.7%) | 8596 / 151510 (5.7%) | −114.0 | −112.0 | 1.89 |
| CDK9 SRX7366781 | MCF-7 Breast | 195 / 15151 (1.3%) | 134 / 151510 (0.1%) | −113.8 | −111.9 | 14.55 |
| KMT2B DRX059614 | HB1119 Blood | 738 / 15151 (4.9%) | 2620 / 151510 (1.7%) | −113.6 | −111.7 | 2.82 |
| BRD2 SRX8090652 | Synoviocytes Others | 1007 / 15151 (6.6%) | 4286 / 151510 (2.8%) | −113.6 | −111.7 | 2.35 |
| CTCF SRX13551281 | Adipose stem cells Adipocyte | 2537 / 15151 (16.7%) | 15668 / 151510 (10.3%) | −113.5 | −111.6 | 1.62 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 322 / 15151 (2.1%) | 9276 / 151510 (6.1%) | −113.3 | −111.4 | 0.35 |
| FOXA1 SRX1161205 | T-47D Breast | 205 / 15151 (1.4%) | 7339 / 151510 (4.8%) | −113.3 | −111.4 | 0.28 |
| GATA1 SRX097108 | K-562 Blood | 1300 / 15151 (8.6%) | 6272 / 151510 (4.1%) | −113.3 | −111.4 | 2.07 |
| KMT2A SRX8151117 | VDH-15 Others | 1774 / 15151 (11.7%) | 9717 / 151510 (6.4%) | −113.2 | −111.3 | 1.83 |
| ZFX SRX3091912 | HCT 116 Digestive tract | 1126 / 15151 (7.4%) | 5082 / 151510 (3.4%) | −113.2 | −111.3 | 2.22 |
| FOXA1 SRX190282 | A549 Lung | 263 / 15151 (1.7%) | 8316 / 151510 (5.5%) | −113.1 | −111.2 | 0.32 |
| KAT6B DRX411443 | 293 Kidney | 1805 / 15151 (11.9%) | 9950 / 151510 (6.6%) | −113.1 | −111.2 | 1.81 |
| Epitope tags SRX15725652 | 293 Kidney | 1537 / 15151 (10.1%) | 7969 / 151510 (5.3%) | −112.9 | −111.0 | 1.93 |
| GRHL3 SRX2582162 | NHEK Epidermis | 890 / 15151 (5.9%) | 3550 / 151510 (2.3%) | −112.9 | −111.0 | 2.51 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1206 / 15151 (8.0%) | 21480 / 151510 (14.2%) | −112.9 | −111.0 | 0.56 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 333 / 15151 (2.2%) | 9439 / 151510 (6.2%) | −112.9 | −111.0 | 0.35 |
| JUNB SRX8488089 | SUM 229PE Breast | 387 / 15151 (2.6%) | 10272 / 151510 (6.8%) | −112.8 | −110.9 | 0.38 |
| ESR1 SRX1469951 | MCF-7 Breast | 196 / 15151 (1.3%) | 7163 / 151510 (4.7%) | −112.7 | −110.8 | 0.27 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 139 / 15151 (0.9%) | 6120 / 151510 (4.0%) | −112.7 | −110.8 | 0.23 |
| GATA3 SRX190194 | SK-N-SH Neural | 881 / 15151 (5.8%) | 17238 / 151510 (11.4%) | −112.5 | −110.6 | 0.51 |
| EP300 SRX1012643 | MCF-7 Breast | 135 / 15151 (0.9%) | 6038 / 151510 (4.0%) | −112.4 | −110.5 | 0.22 |
| BRD4 SRX13134686 | 293 Kidney | 977 / 15151 (6.4%) | 4116 / 151510 (2.7%) | −112.4 | −110.5 | 2.37 |
| KDM6A SRX15826236 | MCF-7 Breast | 117 / 15151 (0.8%) | 5673 / 151510 (3.7%) | −111.9 | −110.0 | 0.21 |
| CTCF SRX12008350 | MCF 10A Breast | 2520 / 15151 (16.6%) | 15591 / 151510 (10.3%) | −111.9 | −110.0 | 1.62 |
| SSRP1 SRX3436567 | HT-1080 Bone | 331 / 15151 (2.2%) | 581 / 151510 (0.4%) | −111.7 | −109.9 | 5.70 |
| NR3C1 SRX8520802 | HCC1187 Breast | 292 / 15151 (1.9%) | 8739 / 151510 (5.8%) | −111.7 | −109.8 | 0.33 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 171 / 15151 (1.1%) | 87 / 151510 (0.1%) | −111.7 | −109.8 | 19.66 |
| KAT6B DRX411444 | 293 Kidney | 1776 / 15151 (11.7%) | 9782 / 151510 (6.5%) | −111.5 | −109.7 | 1.82 |
| TET2 SRX1427029 | 293 Kidney | 1077 / 15151 (7.1%) | 4789 / 151510 (3.2%) | −111.4 | −109.6 | 2.25 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 221 / 15151 (1.5%) | 7546 / 151510 (5.0%) | −111.3 | −109.4 | 0.29 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 339 / 15151 (2.2%) | 9471 / 151510 (6.3%) | −111.2 | −109.3 | 0.36 |
| TAF3 SRX217738 | HCT 116 Digestive tract | 1050 / 15151 (6.9%) | 4618 / 151510 (3.0%) | −111.0 | −109.2 | 2.27 |
| CEBPB SRX190345 | MCF-7 Breast | 307 / 15151 (2.0%) | 8959 / 151510 (5.9%) | −111.0 | −109.2 | 0.34 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 303 / 15151 (2.0%) | 8890 / 151510 (5.9%) | −110.9 | −109.1 | 0.34 |
| ESR1 SRX1012633 | MCF-7 Breast | 201 / 15151 (1.3%) | 7180 / 151510 (4.7%) | −110.6 | −108.8 | 0.28 |
| ESR1 SRX330068 | MCF-7 Breast | 182 / 15151 (1.2%) | 6846 / 151510 (4.5%) | −110.6 | −108.7 | 0.27 |
| KDM5A SRX23740455 | SUM 149PT Breast | 884 / 15151 (5.8%) | 3557 / 151510 (2.3%) | −110.6 | −108.7 | 2.49 |
| FOXA1 SRX219284 | LNCAP Prostate | 520 / 15151 (3.4%) | 12159 / 151510 (8.0%) | −110.4 | −108.5 | 0.43 |
| MECOM SRX23677891 | HNT-34 Blood | 1497 / 15151 (9.9%) | 7751 / 151510 (5.1%) | −110.3 | −108.4 | 1.93 |
| FOXA1 SRX3923511 | MCF-7 Breast | 148 / 15151 (1.0%) | 6214 / 151510 (4.1%) | −110.1 | −108.3 | 0.24 |
| RORC SRX5359053 | HCC70 Breast | 1036 / 15151 (6.8%) | 4549 / 151510 (3.0%) | −110.0 | −108.1 | 2.28 |
| ESR1 SRX4451212 | MCF-7 Breast | 371 / 15151 (2.4%) | 9923 / 151510 (6.5%) | −110.0 | −108.1 | 0.37 |
| STAT3 SRX2020842 | HCC70 Breast | 680 / 15151 (4.5%) | 14395 / 151510 (9.5%) | −109.8 | −107.9 | 0.47 |
| FOXA1 SRX3931031 | MCF-7 Breast | 184 / 15151 (1.2%) | 6854 / 151510 (4.5%) | −109.7 | −107.9 | 0.27 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 374 / 15151 (2.5%) | 9960 / 151510 (6.6%) | −109.7 | −107.9 | 0.38 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 339 / 15151 (2.2%) | 9417 / 151510 (6.2%) | −109.7 | −107.9 | 0.36 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 291 / 15151 (1.9%) | 8651 / 151510 (5.7%) | −109.6 | −107.7 | 0.34 |
| ESR1 SRX8537723 | MCF-7 Breast | 314 / 15151 (2.1%) | 9016 / 151510 (6.0%) | −109.5 | −107.7 | 0.35 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 673 / 15151 (4.4%) | 14285 / 151510 (9.4%) | −109.4 | −107.5 | 0.47 |
| JUNB SRX4192882 | MCF 10A Breast | 314 / 15151 (2.1%) | 9012 / 151510 (5.9%) | −109.4 | −107.5 | 0.35 |
| NCOA3 SRX4663589 | MCF-7 Breast | 109 / 15151 (0.7%) | 5436 / 151510 (3.6%) | −109.1 | −107.3 | 0.20 |
| ARID1A SRX5089382 | MCF-7 Breast | 280 / 15151 (1.8%) | 8451 / 151510 (5.6%) | −109.0 | −107.2 | 0.33 |
| RELA SRX5938177 | FaDu Others | 364 / 15151 (2.4%) | 9776 / 151510 (6.5%) | −108.9 | −107.0 | 0.37 |
| KDM5A SRX23740458 | SUM 149PT Breast | 926 / 15151 (6.1%) | 3855 / 151510 (2.5%) | −108.8 | −106.9 | 2.40 |
| MethylCap SRX014766 | NB-4 Blood | 1306 / 15151 (8.6%) | 6423 / 151510 (4.2%) | −108.7 | −106.9 | 2.03 |
| FOS SRX3322636 | MCF-7 Breast | 257 / 15151 (1.7%) | 8058 / 151510 (5.3%) | −108.5 | −106.6 | 0.32 |
| ARID1A SRX5089388 | MCF-7 Breast | 203 / 15151 (1.3%) | 7143 / 151510 (4.7%) | −108.4 | −106.6 | 0.28 |
| VGLL1 SRX18013277 | FULVR Breast | 174 / 15151 (1.1%) | 6627 / 151510 (4.4%) | −108.3 | −106.4 | 0.26 |
| VGLL1 SRX24602130 | BT-20 Breast | 419 / 15151 (2.8%) | 10588 / 151510 (7.0%) | −108.2 | −106.3 | 0.40 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 110 / 15151 (0.7%) | 5422 / 151510 (3.6%) | −108.1 | −106.3 | 0.20 |
| FOXA1 SRX9604647 | LNCAP Prostate | 589 / 15151 (3.9%) | 13055 / 151510 (8.6%) | −108.1 | −106.2 | 0.45 |
| NR3C1 SRX2609664 | HASM2 Lung | 546 / 15151 (3.6%) | 12441 / 151510 (8.2%) | −108.1 | −106.2 | 0.44 |
| HMG20A SRX2630163 | Hep G2 Liver | 227 / 15151 (1.5%) | 7541 / 151510 (5.0%) | −108.0 | −106.1 | 0.30 |
| NANOG SRX2881137 | hESC H9 Pluripotent stem cell | 113 / 15151 (0.7%) | 5477 / 151510 (3.6%) | −107.9 | −106.1 | 0.21 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 411 / 15151 (2.7%) | 10451 / 151510 (6.9%) | −107.8 | −106.0 | 0.39 |
| SMARCA4 SRX5212357 | Mel270 Others | 552 / 15151 (3.6%) | 12515 / 151510 (8.3%) | −107.8 | −105.9 | 0.44 |
| ESR1 SRX10365534 | MCF-7 Breast | 119 / 15151 (0.8%) | 5592 / 151510 (3.7%) | −107.7 | −105.9 | 0.21 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 242 / 15151 (1.6%) | 286 / 151510 (0.2%) | −107.7 | −105.9 | 8.46 |
| Epitope tags SRX15725650 | 293 Kidney | 1358 / 15151 (9.0%) | 6820 / 151510 (4.5%) | −107.6 | −105.8 | 1.99 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 1287 / 15151 (8.5%) | 6318 / 151510 (4.2%) | −107.6 | −105.7 | 2.04 |
| ESR1 SRX20282966 | MCF-7 Breast | 138 / 15151 (0.9%) | 5947 / 151510 (3.9%) | −107.5 | −105.7 | 0.23 |
| ZEB1 SRX13298925 | MCF-7 Breast | 246 / 15151 (1.6%) | 7840 / 151510 (5.2%) | −107.5 | −105.6 | 0.31 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 80 / 15151 (0.5%) | 4788 / 151510 (3.2%) | −107.4 | −105.6 | 0.17 |
| AR SRX15946405 | MDA-MB-453 Breast | 251 / 15151 (1.7%) | 7921 / 151510 (5.2%) | −107.4 | −105.5 | 0.32 |
| ESR1 SRX5323871 | MCF-7 Breast | 433 / 15151 (2.9%) | 10760 / 151510 (7.1%) | −107.3 | −105.5 | 0.40 |
| EP300 SRX2194265 | SUM 159PT Breast | 603 / 15151 (4.0%) | 13216 / 151510 (8.7%) | −107.3 | −105.4 | 0.46 |
| EP300 SRX1012644 | MCF-7 Breast | 178 / 15151 (1.2%) | 6666 / 151510 (4.4%) | −107.2 | −105.3 | 0.27 |
| KMT2B DRX059615 | HB1119 Blood | 727 / 15151 (4.8%) | 2652 / 151510 (1.8%) | −107.1 | −105.3 | 2.74 |
| ESR1 SRX1012630 | MCF-7 Breast | 152 / 15151 (1.0%) | 6190 / 151510 (4.1%) | −107.1 | −105.2 | 0.25 |
| CREBBP SRX359409 | 293 Kidney | 1321 / 15151 (8.7%) | 6572 / 151510 (4.3%) | −107.0 | −105.2 | 2.01 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 179 / 15151 (1.2%) | 116 / 151510 (0.1%) | −107.0 | −105.2 | 15.43 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 565 / 15151 (3.7%) | 12667 / 151510 (8.4%) | −107.0 | −105.2 | 0.45 |
| TCF12 SRX190356 | SK-N-SH Neural | 1020 / 15151 (6.7%) | 18809 / 151510 (12.4%) | −107.0 | −105.1 | 0.54 |
| AR SRX11149848 | MDA-MB-453 Breast | 252 / 15151 (1.7%) | 7922 / 151510 (5.2%) | −106.9 | −105.1 | 0.32 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 936 / 15151 (6.2%) | 17713 / 151510 (11.7%) | −106.9 | −105.1 | 0.53 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 114 / 15151 (0.8%) | 5457 / 151510 (3.6%) | −106.6 | −104.8 | 0.21 |
| ESR1 SRX5323873 | MCF-7 Breast | 488 / 15151 (3.2%) | 11543 / 151510 (7.6%) | −106.6 | −104.7 | 0.42 |
| AR SRX9468654 | LNCAP Prostate | 447 / 15151 (3.0%) | 10940 / 151510 (7.2%) | −106.5 | −104.7 | 0.41 |
| FOXA1 SRX190181 | A549 Lung | 286 / 15151 (1.9%) | 8465 / 151510 (5.6%) | −106.5 | −104.7 | 0.34 |
Showing first 500 of 17508 rows.